WallStreetZenWallStreetZen

NASDAQ: BCLI
Brainstorm Cell Therapeutics Inc Stock Ownership - Who owns Brainstorm Cell Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Brainstorm Cell Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chaim LebovitsPresident CEO2024-10-011,836$3.43
$6.29kBuy
Chaim LebovitsPresident CEO2024-09-3022,000$0.23
$5.02kBuy
Ibrahim B. DagherChief Medical Officer2024-07-1963,000$0.35
$22.05kSell
Chaim LebovitsPresident CEO2024-05-2815,000$0.52
$7.77kBuy
Chaim LebovitsPresident CEO2024-05-2815,000$0.52
$7.77kBuy
Chaim LebovitsPresident CEO2024-05-2225,000$0.64
$16.00kBuy
Chaim LebovitsPresident CEO2024-05-2225,000$0.64
$16.00kBuy
Chaim LebovitsPresident CEO2024-05-2125,000$0.58
$14.47kBuy
Chaim LebovitsPresident CEO2024-05-2125,000$0.58
$14.47kBuy
Chaim LebovitsPresident CEO2024-05-1310,000$0.49
$4.90kBuy

1 of 2

BCLI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCLI insiders and whales buy or sell their stock.

BCLI Shareholders

What type of owners hold Brainstorm Cell Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Accbt Corp444.73%29,006,924$25.41MInsider
Sankesh Abbhi33.36%2,175,853$1.91MInsider
Ibrahim B. Dagher7.75%505,742$443.03kInsider
Jonathan C. Javitt7.05%460,000$402.96kInsider
Chaim Lebovits5.13%334,349$292.89kInsider
Michael D. Greenfield4.60%300,000$262.80kInsider
Chen Schor3.79%247,116$216.47kInsider
Ralph Dr Kern3.42%223,310$195.62kInsider
Caldwell Sutter Capital Inc2.41%157,009$137.54kInstitution
David Stolick2.30%150,000$131.40kInsider

1 of 3

BCLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCLI1.19%98.81%Net Buying
LYRA40.81%15.59%
GNPX1.21%21.13%Net SellingNet Selling
LIPO0.53%69.70%Net Buying
QNRX7.51%7.08%Net Buying
View Top Biotech Stocks

Brainstorm Cell Therapeutics Stock Ownership FAQ

Who owns Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics (NASDAQ: BCLI) is owned by 6.33% institutional shareholders, 524.48% Brainstorm Cell Therapeutics insiders, and 0.00% retail investors. Accbt Corp is the largest individual Brainstorm Cell Therapeutics shareholder, owning 29.01M shares representing 444.73% of the company. Accbt Corp's Brainstorm Cell Therapeutics shares are currently valued at $24.95M.

If you're new to stock investing, here's how to buy Brainstorm Cell Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.